Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020
Description- About Post-Menopausal Vaginal Atrophy Drugs Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and reduced elasticity of the vaginal tissues. Up to 40% of post-menopausal women have symptoms of atrophic vaginitis. It typically affects women in the age group of 45-55 years. PVA result in symptoms such as itching, burning, dryness, and dyspareunia. Topical preparations such as hormone replacement therapy (HRT) and estrogen creams are used to treat PVA. To Browse a Report Detail with TOC @ http://www.researchmoz.us/global-post-menopausal-vaginal-atrophy-drugs-market-2016-2020-report.html Technavios analysts forecast the global PVA drugs market to grow at a CAGR of 7.13% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global PVA drugs market for 2015-2020. To calculate the